Cargando…
A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring
Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease caused by pathogenic variations in the DMD gene. There is a need for robust DMD biomarkers for diagnostic screening and to aid therapy monitoring. Creatine kinase, to date, is the only routinely used blood biomarker for DMD, although...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049465/ https://www.ncbi.nlm.nih.gov/pubmed/36982290 http://dx.doi.org/10.3390/ijms24065215 |
_version_ | 1785014464818446336 |
---|---|
author | Rossi, Rachele Johansson, Camilla Heywood, Wendy Vinette, Heloise Jensen, Gabriella Tegel, Hanna Jiménez-Requena, Albert Torelli, Silvia Al-Khalili Szigyarto, Cristina Ferlini, Alessandra |
author_facet | Rossi, Rachele Johansson, Camilla Heywood, Wendy Vinette, Heloise Jensen, Gabriella Tegel, Hanna Jiménez-Requena, Albert Torelli, Silvia Al-Khalili Szigyarto, Cristina Ferlini, Alessandra |
author_sort | Rossi, Rachele |
collection | PubMed |
description | Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease caused by pathogenic variations in the DMD gene. There is a need for robust DMD biomarkers for diagnostic screening and to aid therapy monitoring. Creatine kinase, to date, is the only routinely used blood biomarker for DMD, although it lacks specificity and does not correlate with disease severity. To fill this critical gap, we present here novel data about dystrophin protein fragments detected in human plasma by a suspension bead immunoassay using two validated anti-dystrophin-specific antibodies. Using both antibodies, a reduction of the dystrophin signal is detected in a small cohort of plasma samples from DMD patients when compared to healthy controls, female carriers, and other neuromuscular diseases. We also demonstrate the detection of dystrophin protein by an antibody-independent method using targeted liquid chromatography mass spectrometry. This last assay detects three different dystrophin peptides in all healthy individuals analysed and supports our finding that dystrophin protein is detectable in plasma. The results of our proof-of-concept study encourage further studies in larger sample cohorts to investigate the value of dystrophin protein as a low invasive blood biomarker for diagnostic screening and clinical monitoring of DMD. |
format | Online Article Text |
id | pubmed-10049465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100494652023-03-29 A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring Rossi, Rachele Johansson, Camilla Heywood, Wendy Vinette, Heloise Jensen, Gabriella Tegel, Hanna Jiménez-Requena, Albert Torelli, Silvia Al-Khalili Szigyarto, Cristina Ferlini, Alessandra Int J Mol Sci Article Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease caused by pathogenic variations in the DMD gene. There is a need for robust DMD biomarkers for diagnostic screening and to aid therapy monitoring. Creatine kinase, to date, is the only routinely used blood biomarker for DMD, although it lacks specificity and does not correlate with disease severity. To fill this critical gap, we present here novel data about dystrophin protein fragments detected in human plasma by a suspension bead immunoassay using two validated anti-dystrophin-specific antibodies. Using both antibodies, a reduction of the dystrophin signal is detected in a small cohort of plasma samples from DMD patients when compared to healthy controls, female carriers, and other neuromuscular diseases. We also demonstrate the detection of dystrophin protein by an antibody-independent method using targeted liquid chromatography mass spectrometry. This last assay detects three different dystrophin peptides in all healthy individuals analysed and supports our finding that dystrophin protein is detectable in plasma. The results of our proof-of-concept study encourage further studies in larger sample cohorts to investigate the value of dystrophin protein as a low invasive blood biomarker for diagnostic screening and clinical monitoring of DMD. MDPI 2023-03-08 /pmc/articles/PMC10049465/ /pubmed/36982290 http://dx.doi.org/10.3390/ijms24065215 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rossi, Rachele Johansson, Camilla Heywood, Wendy Vinette, Heloise Jensen, Gabriella Tegel, Hanna Jiménez-Requena, Albert Torelli, Silvia Al-Khalili Szigyarto, Cristina Ferlini, Alessandra A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title | A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title_full | A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title_fullStr | A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title_full_unstemmed | A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title_short | A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring |
title_sort | proof of principle proteomic study detects dystrophin in human plasma: implications in dmd diagnosis and clinical monitoring |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049465/ https://www.ncbi.nlm.nih.gov/pubmed/36982290 http://dx.doi.org/10.3390/ijms24065215 |
work_keys_str_mv | AT rossirachele aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT johanssoncamilla aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT heywoodwendy aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT vinetteheloise aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT jensengabriella aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT tegelhanna aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT jimenezrequenaalbert aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT torellisilvia aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT alkhaliliszigyartocristina aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT ferlinialessandra aproofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT rossirachele proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT johanssoncamilla proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT heywoodwendy proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT vinetteheloise proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT jensengabriella proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT tegelhanna proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT jimenezrequenaalbert proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT torellisilvia proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT alkhaliliszigyartocristina proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring AT ferlinialessandra proofofprincipleproteomicstudydetectsdystrophininhumanplasmaimplicationsindmddiagnosisandclinicalmonitoring |